Clinical Trial Update: Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)

View source ↗

Summary

A post-approval safety study update for bazedoxifene in the EU has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Bazedoxifene (bazedoxifene)

Snippet

Sponsor: Pfizer | Conditions: Osteoporosis, Postmenopausal | Status: COMPLETED | Results posted: 2020-05-18